CAC
MSAC

Cowen and Company’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Cowen and Company’s Portfolio MSAC Stock Details MSAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-500,000
Closed -$4.9M – 818
2022
Q2 		$4.9M Hold
500,000
– – 0.47% 44
2022
Q1 		$4.89M Buy
+500,000
New +$4.86M 0.47% 41

Other funds holding MSAC

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Cowen and Company's MSAC Position: Q3 2022 in Review

Cowen and Company sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q3 2022, closing a stake of 500,000 shares — an estimated $4.9M sold.

Cowen and Company first reported a position in MSAC in Q1 2022 and held it in 2 quarters. The position peaked at $4.9M in Q2 2022. 53 funds tracked by Wall St. Rank hold MSAC as of Q3 2022.

  • Cowen and Company reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q3 2022 after selling out during the quarter.
  • Cowen and Company sold 500,000 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q3 2022, an estimated $4.9M.
  • Cowen and Company first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q1 2022 and held it in 2 quarters.
  • Cowen and Company's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $4.9M in Q2 2022.
  • 53 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q3 2022.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.